PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 6483118-0 1984 Effect of fentanyl and naloxone on the P300 auditory potential. Fentanyl 10-18 E1A binding protein p300 Homo sapiens 39-43 6483118-0 1984 Effect of fentanyl and naloxone on the P300 auditory potential. Naloxone 23-31 E1A binding protein p300 Homo sapiens 39-43 6483118-1 1984 The effect of fentanyl (opioid agonist) and naloxone (morphine antagonist) on the amplitude, area and latency of the P300 auditory potential was studied in patients undergoing minor surgical procedures. Fentanyl 14-22 E1A binding protein p300 Homo sapiens 117-121 6483118-1 1984 The effect of fentanyl (opioid agonist) and naloxone (morphine antagonist) on the amplitude, area and latency of the P300 auditory potential was studied in patients undergoing minor surgical procedures. Naloxone 44-52 E1A binding protein p300 Homo sapiens 117-121 6483118-1 1984 The effect of fentanyl (opioid agonist) and naloxone (morphine antagonist) on the amplitude, area and latency of the P300 auditory potential was studied in patients undergoing minor surgical procedures. Morphine 54-62 E1A binding protein p300 Homo sapiens 117-121 6483118-4 1984 Concomitantly, fentanyl increased the number of omitted counts of the target tones of the "odd ball" P300 test and the spatial threshold of the two point discrimination test in patients with small and large P300 potentials. Fentanyl 15-23 E1A binding protein p300 Homo sapiens 101-105 6483118-4 1984 Concomitantly, fentanyl increased the number of omitted counts of the target tones of the "odd ball" P300 test and the spatial threshold of the two point discrimination test in patients with small and large P300 potentials. Fentanyl 15-23 E1A binding protein p300 Homo sapiens 207-211 6483118-5 1984 Naloxone significantly increased the amplitude and area and decreased the latency of the small P300 potential and decreased the amplitude and area with no changes in latency of the large P300 potentials. Naloxone 0-8 E1A binding protein p300 Homo sapiens 95-99 6483118-6 1984 Concomitantly, naloxone decreased the number of omitted counts of the patients with small but not large P300 potentials and decreased the spatial threshold in patients with both small and large P300 potentials. Naloxone 15-23 E1A binding protein p300 Homo sapiens 104-108 6483118-6 1984 Concomitantly, naloxone decreased the number of omitted counts of the patients with small but not large P300 potentials and decreased the spatial threshold in patients with both small and large P300 potentials. Naloxone 15-23 E1A binding protein p300 Homo sapiens 194-198